Treatment outcomes and relative dose intensity of chemotherapy in patients with advanced Hodgkin lymphoma

The present retrospective study was undertaken to investigate the association of relative dose intensity (RDI) with the outcome of patients with advanced stage Hodgkin lymphoma (HL) receiving ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) and escalated BEACOPP regimens (bleomycin, etoposide...

Descripción completa

Detalles Bibliográficos
Autores principales: Rožman, Samo, Jezeršek Novaković, Barbara, Ružić Gorenjec, Nina, Novaković, Srdjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353858/
https://www.ncbi.nlm.nih.gov/pubmed/35949614
http://dx.doi.org/10.3892/ol.2022.13440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353858/
https://www.ncbi.nlm.nih.gov/pubmed/35949614
http://dx.doi.org/10.3892/ol.2022.13440

Ejemplares similares